Skip to main content

Kanecia Obie Zimmerman

Wilburt C. Davison Distinguished Professor
Pediatrics, Critical Care Medicine
300 West Morgan Street, Durham, NC 27710

Current Appointments & Affiliations


Wilburt C. Davison Distinguished Professor · 2024 - Present Pediatrics, Critical Care Medicine, Pediatrics
Professor of Pediatrics · 2023 - Present Pediatrics, Critical Care Medicine, Pediatrics
Membership in the Duke Clinical Research Institute · 2015 - Present Duke Clinical Research Institute, Institutes and Centers

In the News


Published March 19, 2024
Duke Awards 32 New Distinguished Professorships for 2024
Published September 16, 2022
No More Guessing on the Right Dosage for Children
Published September 16, 2022
No More Guessing on the Right Dosage for Children

View All News

Recent Publications


A comprehensive outside-of-school intervention to promote school attendance and achievement during the COVID-19 pandemic.

Journal Article Public Health Pract (Oxf) · June 2026 OBJECTIVES: School absenteeism predicts poor academic achievement and long-term health inequities. Chronic absenteeism increased dramatically during the COVID-19 pandemic, and both student attendance and achievement disparities widened. This study examined ... Full text Link to item Cite

Evaluation of electronic health record to HL7® FHIR® mappings in pediatric research studies.

Journal Article Int J Med Inform · April 1, 2026 BACKGROUND: eSource technologies that exchange patient data from electronic health records (EHR) to clinical study electronic data capture (EDC) systems can reduce data quality errors and decrease data collection time. However, the availability of site-spe ... Full text Link to item Cite

Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity.

Journal Article Clin Pharmacokinet · February 2026 BACKGROUND: Oxcarbazepine (OXZ) is an antiepileptic drug whose pharmacological effect is primarily mediated by its active metabolite, 10-monohydroxy derivative (MHD). OXZ is approved for use in adults and children older than 2 years with an age- and body w ... Full text Link to item Cite
View All Publications

Recent Grants


1/3 CTSA UM1 at Duke University

ResearchCore Leader · Awarded by National Institutes of Health · 2025 - 2032

iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2025 - 2030

2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Institutes of Health · 2025 - 2030

View All Grants

Education, Training & Certifications


Duke University, School of Medicine · 2007 M.D.
University of North Carolina, Chapel Hill · 2006 M.P.H.